Imrab 3

17 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

590.0%

Death Rate

Active Ingredients

Imrab 3

Administration Routes

UnknownSubcutaneousIntramuscular

Species Affected

Dog 15

Horse 1

Cattle 1

Most Affected Breeds

Shepherd Dog - German 3

Terrier - Bull - American Pit 2

Pug 2

Bulldog 1

Terrier - Yorkshire 1

Chihuahua 1

Mustang 1

Bichon Frise 1

Dachshund (unspecified) 1

Guernsey 1

Most Reported Reactions

Vomiting 6

Lethargy (see also Central nervous system depression in 'Neurological') 4

Lethargy (see also Central nervous system depression in Neurological) 4

Facial swelling (see also Skin) 4

Diarrhoea 3

Not eating 2

Anaphylaxis 2

Hives (see also 'Skin') 1

Swelling NOS 1

Allergic reaction 1

Shivering 1

Vocalisation 1

Outcome Breakdown

Recovered/Normal

8 (47.1%)

Ongoing

6 (35.3%)

Outcome Unknown

2 (11.8%)

Died

1 (5.9%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.